Cerity Partners LLC Buys 19,846 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Cerity Partners LLC grew its position in shares of Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 145.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 33,532 shares of the business services provider's stock after acquiring an additional 19,846 shares during the quarter. Cerity Partners LLC's holdings in Stericycle were worth $1,662,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of SRCL. Quarry LP bought a new stake in shares of Stericycle during the first quarter valued at approximately $30,000. Ancora Advisors LLC bought a new stake in shares of Stericycle during the first quarter valued at approximately $34,000. International Assets Investment Management LLC bought a new stake in Stericycle during the third quarter worth $36,000. First Capital Advisors Group LLC. bought a new stake in Stericycle during the second quarter worth $36,000. Finally, Point72 Middle East FZE bought a new stake in Stericycle during the fourth quarter worth $39,000. Institutional investors own 98.82% of the company's stock.

Stericycle Stock Performance

SRCL stock traded up $1.04 during midday trading on Friday, hitting $49.91. The company's stock had a trading volume of 444,564 shares, compared to its average volume of 361,797. The stock's 50-day moving average price is $51.41 and its 200 day moving average price is $47.99. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.51. Stericycle, Inc. has a 1 year low of $37.78 and a 1 year high of $57.06. The stock has a market cap of $4.63 billion, a price-to-earnings ratio of -207.95, a PEG ratio of 2.64 and a beta of 1.09.

Stericycle (NASDAQ:SRCL - Get Free Report) last posted its quarterly earnings data on Wednesday, February 28th. The business services provider reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.07. Stericycle had a positive return on equity of 7.06% and a negative net margin of 0.80%. The business had revenue of $652.00 million for the quarter, compared to analysts' expectations of $657.99 million. During the same quarter in the previous year, the firm earned $0.60 earnings per share. The business's revenue was down 2.7% on a year-over-year basis. On average, equities analysts forecast that Stericycle, Inc. will post 2.31 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on SRCL shares. Stifel Nicolaus upped their price target on Stericycle from $70.00 to $75.00 and gave the stock a "buy" rating in a report on Thursday, February 29th. Truist Financial upped their price target on Stericycle from $50.00 to $57.00 and gave the stock a "hold" rating in a report on Thursday, February 29th. StockNews.com downgraded Stericycle from a "buy" rating to a "hold" rating in a report on Tuesday, April 2nd. Royal Bank of Canada reissued an "outperform" rating and issued a $69.00 price objective on shares of Stericycle in a research report on Thursday, March 7th. Finally, Wells Fargo & Company boosted their price objective on Stericycle from $40.00 to $48.00 and gave the stock an "underweight" rating in a research report on Friday, March 1st. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Stericycle has a consensus rating of "Hold" and an average price target of $62.25.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.